Australian University Rankings Guide

Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine (ERA Journal)

Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine issns are issn1: 1535-2811 issn2: 1535-282X.

The fields covered by Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine as part of the evaluation of Australian university research excellence are:

Cardiorespiratory Medicine and Haematology Research Rankings (Sub-Field)

Clinical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Cardiorespiratory Medicine and Haematology field include:

- Acta Angiologica
- Archives of Cardiovascular Diseases Supplements
- British Journal of Cardiac Nursing
- Cardiology
- Cardiovascular and Interventional Radiology
- Circulation
- Circulation: Cardiovascular Quality and Outcomes
- Congestive Heart Failure
- Heart Failure Reviews
- Hematology / Oncology Clinics of North America
- Journal of Clinical Hypertension
- Journal of Emergencies Trauma and Shock: synergizing basic science clinical medicine and global health
- Journal of Interventional Cardiology: an international forum for global cardiovascular therapies
- Nature Reviews Cardiology
- Phlebologie


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4